FEDERAL LOBBYING RECORDS
LOBBYING FILINGS AND MARKET CONTEXT
Indexed federal lobbying filings mapped to clients, registrants, and public-company tickers. Transaction dates are compared with filing periods to identify date-proximity review flags. Proximity does not establish coordination, influence, or wrongdoing.
Filings tracked
20,641
thru 2026-07-15
Total reported $
$2.7B
disclosed lobbying
Distinct clients
2,260
paying companies
Tickers targeted
1,219
public companies
Clients by reported amount
| # | Client | Filings | Total $ |
|---|---|---|---|
| 1 |  PFIZER INC.PFE | 48 | $46.9M |
| 2 |  GENERAL MOTORS COMPANYGM | 61 | $46.8M |
| 3 |  META PLATFORMS INC. AND VARIOUS SUBSIDIARIESMETA | 13 | $45.0M |
| 4 | VISA INC.V | 46 | $37.7M |
| 5 |  AMAZON.COM SERVICES LLCAMZN | 37 | $32.8M |
| 6 |  LOCKHEED MARTIN CORPORATIONLMT | 76 | $29.1M |
| 7 |  FEDEX CORPORATIONFDXW | 71 | $27.9M |
| 8 |  ELI LILLY AND COMPANYLLY | 60 | $27.4M |
| 9 |  ALTRIA CLIENT SERVICES LLCMO | 147 | $25.3M |
| 10 |  COMCAST CORPORATIONCMCSV | 183 | $24.9M |
| 11 |  AMGEN INCAMGN | 19 | $24.9M |
| 12 |  MERCK & CO INCMRK | 14 | $24.0M |
| 13 |  SOUTHERN COMPANYSO | 54 | $23.9M |
| 14 |  GOOGLE CLIENT SERVICES LLCGOOGL | 83 | $22.8M |
| 15 |  APPLE INCAAPL | 9 | $22.1M |
| 16 |  T-MOBILE USA INC.TMUS | 131 | $21.3M |
| 17 |  UNITEDHEALTH GROUP INCUNH | 19 | $20.4M |
| 18 |  VERIZON COMMUNICATIONS INC AND VARIOUS SUBSIDIARIESVZ | 41 | $20.1M |
| 19 |  OCCIDENTAL PETROLEUM CORPORATIONOXY | 32 | $19.8M |
| 20 |  MICROSOFT CORPORATIONMSFT | 107 | $18.9M |
| 21 |  QUALCOMM INCORPORATEDQCOM | 40 | $17.2M |
| 22 |  BOEING COMPANYBA | 24 | $17.0M |
| 23 |  GENERAL DYNAMICS CORPGD | 11 | $17.0M |
| 24 | THE CIGNA GROUP AND SUBSIDIARIES (FORMERLY CIGNA CORPORATION AND SUBSIDIARIES)CI | 13 | $16.9M |
| 25 |  ORACLE CORPORATIONORCL | 60 | $16.8M |
Mapped tickers by reported amount
| # | Ticker | Filings | Total $ |
|---|---|---|---|
| 1 | META Meta Platforms Inc. | 134 | $50.3M |
| 2 | PFE Pfizer Inc. | 89 | $48.7M |
| 3 | GM General Motors Company | 103 | $48.4M |
| 4 | V Visa Inc. | 47 | $37.7M |
| 5 | AMZN Amazon.com Inc. | 82 | $35.4M |
| 6 | LMT Lockheed Martin Corporation | 92 | $29.5M |
| 7 | FDX FedEx Corporation | 83 | $28.4M |
| 8 | LLY Eli Lilly and Company | 88 | $28.4M |
| 9 | AMGN Amgen Inc. | 100 | $28.0M |
| 10 | MRK Merck & Co. Inc. | 92 | $27.5M |
| 11 | AAPL Apple Inc. | 66 | $27.0M |
| 12 | GOOGL Alphabet Inc. Class A | 128 | $26.8M |
| 13 | MO | 172 | $26.4M |
| 14 | SO Southern Company | 110 | $26.2M |
| 15 | UNH UnitedHealth Group Inc. | 68 | $24.0M |
| 16 | VZ Verizon Communications Inc. | 119 | $23.8M |
| 17 | TMUS | 170 | $22.9M |
| 18 |  CHTR | 142 | $22.8M |
| 19 | GD General Dynamics Corporation | 131 | $22.6M |
| 20 |  TAT&T Inc. | 137 | $21.7M |
| 21 | ORCL Oracle Corporation | 135 | $20.8M |
| 22 | CMCSA Comcast Corporation | 142 | $20.5M |
| 23 | OXY Occidental Petroleum Corporation | 38 | $20.1M |
| 24 | CI The Cigna Group | 64 | $19.9M |
| 25 | MSFT Microsoft Corporation | 126 | $19.3M |
🆕 Filtered Filings · EMERGENT BIOSOLUTIONS INC
clear filters| Date | Ticker | Client | Registrant | Amount | Issue |
|---|---|---|---|---|---|
| 2026-07-14 | EBS | EMERGENT BIOSOLUTIONS INC | EMERGENT BIOSOLUTIONS INC. | $510K | - Reauthorization of Protecting Americans from All-Hazards Preparedness Act - Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27 - Opioid crisis legislation, naloxone access and awareness - State opioid response (SOR) Grant funding FY27 Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27 Tribal Opioid Response Grant funding for FY27 H.R. 8800/S. 4784 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone H.R. 5252, Having Overdoes Protection Equipment Act Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act (H.R. 8870, S. TBD) - Reauthorization of Protecting Americans from All-Hazards Preparedness Act - Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedica |
| 2026-04-14 | EBS | EMERGENT BIOSOLUTIONS INC | EMERGENT BIOSOLUTIONS INC. | $730K | - Reauthorization of Protecting Americans from All-Hazards Preparedness Act - Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27 - Opioid crisis legislation, naloxone access and awareness - State opioid response (SOR) Grant funding FY27 - Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27 - Tribal Opioid Response Grant funding for FY27 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone - H.R. 5252, Having Overdoes Protection Equipment Act - Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act - Reauthorization of Protecting Americans from All-Hazards Preparedness Act - Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Develo |
| 2026-01-16 | EBS | EMERGENT BIOSOLUTIONS INC | EMERGENT BIOSOLUTIONS INC. | $430K | - Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act - Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield forFY26 - Opioid crisis legislation, naloxone access and awareness - State opioid response (SOR) Grant funding FY26 - Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY26 - Tribal Opioid Response Grant funding for FY26 - NDAA for Fiscal Year 2025 and Fiscal Year 2026 - provisions related to biological and chemical defense and access to naloxone - H.R. 1968, the Full-Year Continuing Appropriations and Extensions Act, 2025 - H.R. 2483, SUPPORT for Patients and Communities Reauthorization Act of 2025 - H.R. 5252, Having Overdoes Protection Equipment Act - Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act - Reauthorization of P |
| 2025-10-15 | EBS | EMERGENT BIOSOLUTIONS INC | EMERGENT BIOSOLUTIONS INC. | $530K | - Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act - Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY26 - Opioid crisis legislation, naloxone access and awareness - State opioid response (SOR) Grant funding FY26 - Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY26 - Tribal Opioid Response Grant funding for FY26 - NDAA for Fiscal Year 2025 and Fiscal Year 2026 - provisions related to biological and chemical defense and access to naloxone - H.R.1968, the Full-Year Continuing Appropriations and Extensions Act, 2025 - H.R.2483, SUPPORT for Patients and Communities Reauthorization Act of 2025 - H.R.5252, Having Overdoes Protection Equipment Act - Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act - Funding for medical countermeasure enterprise inclu |
| 2025-07-16 | EBS | EMERGENT BIOSOLUTIONS INC | EMERGENT BIOSOLUTIONS INC. | $440K | - Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act - Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY25 and FY26 - Opioid crisis legislation, naloxone access and awareness - State opioid response (SOR) Grant funding FY25 and FY26 - Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY25 and FY26 - Tribal Opioid Response Grant funding for FY26 - NDAA for Fiscal Year 2025 and Fiscal Year 2026 - provisions related to biological and chemical defense and access to naloxone - H.R.1968, the Full-Year Continuing Appropriations and Extensions Act, 2025 - Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act - Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA |
| 2025-04-15 | EBS | EMERGENT BIOSOLUTIONS INC | EMERGENT BIOSOLUTIONS INC. | $920K | Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY25 and FY26 Opioid crisis legislation, naloxone access and awareness State opioid response (SOR) Grant funding FY25 and FY26 Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY25 and FY26 NDAA for Fiscal Year 2025 and Fiscal Year 2026 - provisions related to biological and chemical defense and access to naloxone H.R. 1968, the Full-Year Continuing Appropriations and Extensions Act, 2025 Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY25 and FY26 Opioid crisis legislat |